ArticleBMC cancer2026

Curative-intent tri-modality treatment of de novo bone-only oligometastatic breast cancer: single-center patient outcomes.

Joseff Karl Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.